Hubei Guangji Pharmaceutical Co Ltd (000952) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.38 Million ≈ $3.27 Million USD) by net assets (CN¥963.20 Million ≈ $140.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hubei Guangji Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Hubei Guangji Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Guangji Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Iljin HySolus Co Ltd
KO:271940
|
0.008x |
|
E Split Corp Class A
TO:ENS
|
0.100x |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
0.017x |
|
Leysen Jewellery Inc
SHG:603900
|
0.027x |
|
Arvind SmartSpaces Limited
NSE:ARVSMART
|
0.168x |
|
Palisade Bio Inc
NASDAQ:PALI
|
-0.031x |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class B
IS:KRDMB
|
0.031x |
|
Korea Ratings Co. Ltd
KQ:034950
|
0.035x |
Annual Cash Flow Conversion Efficiency for Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Hubei Guangji Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥626.85 Million ≈ $91.73 Million |
CN¥60.43 Million ≈ $8.84 Million |
0.096x | +15730.22% |
| 2024-12-31 | CN¥1.08 Billion ≈ $157.48 Million |
CN¥655.36K ≈ $95.90K |
0.001x | +100.57% |
| 2023-12-31 | CN¥1.39 Billion ≈ $203.76 Million |
CN¥-148.96 Million ≈ $-21.80 Million |
-0.107x | -454.02% |
| 2022-12-31 | CN¥1.49 Billion ≈ $218.30 Million |
CN¥45.08 Million ≈ $6.60 Million |
0.030x | -42.24% |
| 2021-12-31 | CN¥1.45 Billion ≈ $212.30 Million |
CN¥75.91 Million ≈ $11.11 Million |
0.052x | -40.15% |
| 2020-12-31 | CN¥1.37 Billion ≈ $199.84 Million |
CN¥119.38 Million ≈ $17.47 Million |
0.087x | -41.54% |
| 2019-12-31 | CN¥964.30 Million ≈ $141.11 Million |
CN¥144.20 Million ≈ $21.10 Million |
0.150x | -43.08% |
| 2018-12-31 | CN¥880.96 Million ≈ $128.91 Million |
CN¥231.44 Million ≈ $33.87 Million |
0.263x | +12.42% |
| 2017-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥178.83 Million ≈ $26.17 Million |
0.234x | -7.80% |
| 2016-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥167.07 Million ≈ $24.45 Million |
0.253x | +490.58% |
| 2015-12-31 | CN¥513.86 Million ≈ $75.19 Million |
CN¥-33.35 Million ≈ $-4.88 Million |
-0.065x | +56.09% |
| 2014-12-31 | CN¥505.45 Million ≈ $73.96 Million |
CN¥-74.69 Million ≈ $-10.93 Million |
-0.148x | -214.15% |
| 2013-12-31 | CN¥735.04 Million ≈ $107.56 Million |
CN¥95.16 Million ≈ $13.92 Million |
0.129x | -8.91% |
| 2012-12-31 | CN¥760.05 Million ≈ $111.22 Million |
CN¥108.02 Million ≈ $15.81 Million |
0.142x | +49.90% |
| 2011-12-31 | CN¥863.60 Million ≈ $126.37 Million |
CN¥81.88 Million ≈ $11.98 Million |
0.095x | +3.11% |
| 2010-12-31 | CN¥839.35 Million ≈ $122.82 Million |
CN¥77.18 Million ≈ $11.29 Million |
0.092x | +408.50% |
| 2009-12-31 | CN¥816.91 Million ≈ $119.54 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.030x | -110.96% |
| 2008-12-31 | CN¥811.28 Million ≈ $118.72 Million |
CN¥220.70 Million ≈ $32.30 Million |
0.272x | -44.85% |
| 2007-12-31 | CN¥673.00 Million ≈ $98.48 Million |
CN¥331.98 Million ≈ $48.58 Million |
0.493x | +87.08% |
| 2006-12-31 | CN¥477.68 Million ≈ $69.90 Million |
CN¥125.95 Million ≈ $18.43 Million |
0.264x | +158.99% |
| 2005-12-31 | CN¥531.76 Million ≈ $77.81 Million |
CN¥54.14 Million ≈ $7.92 Million |
0.102x | +1705.73% |
| 2004-12-31 | CN¥523.19 Million ≈ $76.56 Million |
CN¥-3.32 Million ≈ $-485.42K |
-0.006x | +78.81% |
| 2003-12-31 | CN¥514.56 Million ≈ $75.30 Million |
CN¥-15.40 Million ≈ $-2.25 Million |
-0.030x | -119.91% |
| 2002-12-31 | CN¥506.86 Million ≈ $74.17 Million |
CN¥76.20 Million ≈ $11.15 Million |
0.150x | +426.75% |
| 2001-12-31 | CN¥486.87 Million ≈ $71.24 Million |
CN¥-22.40 Million ≈ $-3.28 Million |
-0.046x | -145.62% |
| 2000-12-31 | CN¥481.54 Million ≈ $70.46 Million |
CN¥48.57 Million ≈ $7.11 Million |
0.101x | -33.92% |
| 1999-12-31 | CN¥449.30 Million ≈ $65.75 Million |
CN¥68.57 Million ≈ $10.03 Million |
0.153x | +291.61% |
| 1998-12-31 | CN¥191.95 Million ≈ $28.09 Million |
CN¥-15.29 Million ≈ $-2.24 Million |
-0.080x | -- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.